Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)
Dowd, P.M.; Martin, M.F.; Cooke, E.D.; Bowcock, S.A.; Jones, R.; Dieppe, P.A.; Kirby, J.D.
British Journal of Dermatology 106(1): 81-89
1982
ISSN/ISBN: 0007-0963 PMID: 7037038 Document Number: 195286
Patients (25) with Raynaud's phenomenon due to systemic sclerosis were infused with prostacyclin (PGI2) monitored by thermography or radiometry.
Document emailed within 1 workday
Related Documents
Cuenca, R.; Fernández-Cortijo, J.; Lima, J.; Fonollosa, V.; Simeón, C.P.; Pico, M.; Soriano, B.; Vilardell, M. 1990: Platelet function study in primary Raynaud's phenomenon and Raynaud's phenomenon associated with scleroderma Medicina Clinica 95(20): 761-763Pratesi, F.; Corsi, C.; Deidda, C.; Nuti, A. 1976: Raynaud's phenomenon and Raynaud's disease definition of Raynaud's phenomenon Schweizerische Rundschau für Medizin Praxis 65(44): 1368-1370
Acevedo, A.; Arinoviche, R.; Palma, A.; Olea, E.; Guzmán, G.; Arriagada, M.; Grisanti, M.; Testar, R. 1982: Reserpine administration by retrograde intravenous route in patients with Raynaud's phenomenon Revista Medica de Chile 110(11): 1063-1065
Arenas, G.; Del Buono, R.; Oyarzún, M.J.; Donoso, P.; Quijada, D. 1989: Pulmonary response to free fatty acid intravenous infusion in the rabbit: role of leukotrienes and the effect of prostacyclin Archivos de Biologia Y Medicina Experimentales 22(4): 379-385
Bart, P.A.; Waeber, B. 2006: Understanding Raynaud's phenomenon: towards a better treatment Revue Medicale Suisse 2(48): 93-96
Thulesius, O. 1979: Psychiatric treatment of Raynaud's phenomenon Lakartidningen 76(47): 4234
Adair, J.R.; Theobald, D.E. 1978: Raynaud's Phenomenon: treatment of a severe case with biofeedback Journal of the Indiana State Medical Association 71(10): 990-993
Buryĭ, V.T.; Buryĭ, V.V. 2008: The treatment of neurospastic vascular diseases in Raynaud phenomenon Klinichna Khirurhiia 6: 36-39
Di Biase, A. 2013: Mesoglycan treatment in Raynaud phenomenon: a case series Minerva Cardioangiologica 61(3): 323-331
Delgado Daza, R.; Moga Donadeu, L.; Mañosa Bonamich, J.; Muncunill Gil, J.; Vidal Conde, V. 1991: Thoracic sympathectomy in the surgical treatment of Raynaud's phenomenon Angiologia 43(5): 180-182
Kahan, A.; Weber, S.; Amor, B.; Guerin, F.; Degeorges, M. 1983: Nifedipine in the treatment of migraine in patients with Raynaud's phenomenon New England Journal of Medicine 308(18): 1102-1103
Lakshminarayanan, S.; Vázquez-Abad, D.; Maestrello, S.J.; Waterman, J.R. 1999: Treatment of severe Raynaud's phenomenon and ischemic ulcerations with tissue plasimogen activator Clinical and Experimental Rheumatology 17(2): 260
Zicot, M. 1980: Symptomatic treatment of Raynaud's phenomenon: reserpine, alpha-methyldopa, griseofulvin, guanethidine Revue Medicale de Liege 35(19): 652-654
Belch, J.J.; Shaw, B.; O'Dowd, A.; Saniabadi, A.; Leiberman, P.; Sturrock, R.D.; Forbes, C.D. 1985: Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study Thrombosis and Haemostasis 54(2): 490-494
Ranieri, G.; De Mitrio, V.; Petronelli, M.; Ancona, A.; Dammacco, F. 1988: Use of defibrotide in the treatment of Raynaud's phenomenon associated with progressive systemic sclerosis or essential mixed cryoglobulinemia La Clinica Terapeutica 126(5): 335-343
Kyle, M.V.; Belcher, G.; Hazleman, B.L. 1992: Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon Journal of Rheumatology 19(9): 1403-1406
Neuhauser, B.; Perkmann, R.; Klingler, P.J.; Giacomuzzi, S.; Kofler, A.; Fraedrich, G. 2001: Clinical and objective data on spinal cord stimulation for the treatment of severe Raynaud's phenomenon American Surgeon 67(11): 1096-1097
Lasfargues, G.; Royere, D.; Perrotin, D.; Titon, J.P.; Soutif, D.; Guilmot, J.L. 1987: Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon Journal des Maladies Vasculaires 12(4): 319-322
Da Costa, J.; Gomes, J.A.; Espirito Santo, J.; Queirós, M. 1987: Inefficacy of diltiazem in the treatment of Raynaud's phenomenon with associated connective tissue disease: a double blind placebo controlled study Journal of Rheumatology 14(4): 858-859
Varela-Aguilar, J.M.; Sánchez-Román, J.; Talegón Meléndez, A.; Castillo Palma, M.J. 1997: Comparative study of misoprostol and nifedipine in the treatment of Raynaud's phenomenon secondary to systemic diseases. Hemodynamic assessment with Doppler duplex Revista Clinica Espanola 197(2): 77-83